VEGFA and neoplasm: Preclinical studies have revealed that vascular endothelial growth factor (VEGF) and vascular endothelial growth factor A (VEGF‐A) are detected in tumor lesions, and VEGF and VEGF‐A expression are positively correlated with pathological grade of bone sarcoma and negatively correlated with progression‐free survival (PFS).